Magnetic Resonance Imaging Using Innovative Pulse Sequences

Completed

• Conditions: 10029211; 10011305; Brain disease; 10027584

• Registration Number: NL-OMON37074
• Lead Sponsor: GE Healthcare MR Business

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 29 April 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 40

Inclusion Criteria

• Subject must be at least eighteen (18) years of age; and
• Subject must be willing and able to undergo verbal and written informed consent; and
• Subject must have a clinical indication for a head MRI with and without Gadolinium-based contrast agent administration

Exclusion Criteria

• Any contraindication to administration of an MRI contrast agent.
• Off-label utilization of contrast agents administered for the subject*s clinical exam.

Study & Design

• Study Type: Observational invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Image quality.</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>NVT</p><br>